The efficacy and safety of observation therapy or terazosin 2mg or 5mg administration for Distal Ureter Stone Patients

The efficacy and safety of observation therapy or terazosin 2mg or 5mg administration for Distal Ureter Stone patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0005052

Enrollment

194

Registered

2020-05-22

Start date

2020-07-02

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1) Observational therapy group 2) terazosin 2mg QD for 4 weeks group 3) terazosin 5mg QD for 4 weeks group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Men over 19 2) Those with lower urinary tract stones less than 10mm in diameter 3) A person who voluntarily decides to participate in this study and agrees in writing to the subject consent

Exclusion criteria

Exclusion criteria: 1) People with urinary tract infection 2) A person with a severe hydronephrosis 3) Those who have multiple stones 4) Patients with ureteral stenosis 5) Patients who are currently taking Calcium Channel Blocker or Alpha Blocker 6) Those who are sensitive to alpha-blocker preparations 7) Patients with Systolic blood pressure <110mmHg 8) Patients who has a history of surgery related to the urinary tract 9) Others who are inappropriate to participate in research as judged by the Primary Investigator or other Investigators

Design outcomes

Primary

Measure	Time frame
Natural excretion rate of lower urinary tract stones when waiting therapy or terazosin 2mg or 5mg was administered to patients with lower urinary tract stones for 4 weeks	—

Secondary

Measure	Time frame
The average number of days it takes for the lower urinary tract stones to be discharged when observational therapy or terazosin 2 mg or 5 mg is administered for up to 4 weeks to patients with lower urinary tract stones.	—

Countries

Korea, Republic of

Contacts

Public ContactChoi Seung kwon

Seoul Medical Center

Outcome results